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Contraction is a critical phase of immunity whereby
the vast majority of effector T cells die by apoptosis,
sparing a population of long-lived memory cells.
Where, when, and why contraction occurs has been
difficult to address directly due in large part to the
rapid clearance of apoptotic T cells in vivo. To
circumvent this issue, we introduced a genetically
encoded reporter for caspase-3 activity into naive
T cells to identify cells entering the contraction
phase. Using two-photon imaging, we found that
caspase-3 activity in T cells was maximal at the
peak of the response and was associated with loss
of motility followed minutes later by cell death. We
demonstrated that contraction is a widespread
process occurring uniformly in all organs tested
and targeting phenotypically diverse T cells. Impor-
tantly, we identified a critical window of time during
which antigen encounters act to antagonize T cell
apoptosis, supporting a causal link between antigen
clearance and T cell contraction. Our results offer
insight into a poorly explored phase of immunity
and provide a versatile methodology to study
apoptosis during the development or function of
a variety of immune cells in vivo.INTRODUCTION
A core tenet in immunology is that protective T cell immunity
develops in a triphasic manner, classically categorized into the
three discrete phases of expansion, contraction, and memory
(Sallusto et al., 2010). In brief, initial encounter with antigens
derived from an infectious agent triggers the activation and
robust proliferation of antigen-specific T cell clones. This expan-
sion phase is followed by a precipitous decline in cell numbers
(Badovinac and Harty, 2006; D’Cruz et al., 2009; Marrack
et al., 2010; McKinstry et al., 2010). The remaining 5%–10% of
activated T cells that survive the contraction phase go on to1438 Cell Reports 2, 1438–1447, November 29, 2012 ª2012 The Autseed the memory pool (Kaech et al., 2002). Although much
insight has been gained into the expansion and memory phases
of the response, the mechanisms that underlie contraction
remain to be clarified.
T cell contraction has been shown to operate through both the
intrinsic and extrinsic pathways of apoptosis as a consequence
of cytokine deprivation or engagement of death receptors,
respectively (D’Cruz et al., 2009; Krammer et al., 2007; Marrack
and Kappler, 2004). With the observation that the generation of
greater memory T cell numbers following immunization corre-
lates well with enhanced memory function (Harty and Badovi-
nac, 2008), it is of critical importance for vaccine development
to understand the mechanisms that regulate the process of
effector T cell attrition. It was initially proposed that contraction
was linked to antigen clearance, as the timing of these events
often coincide (Sprent and Tough, 2001). Consistent with this
possibility, in vitro experiments using highly activated T cells
have shown that withdrawal of TCR stimulation can result in
apoptosis (Harbertson et al., 2002; McKinstry et al., 2007).
However, the role of antigen in regulating contraction in vivo
has not directly been established. In fact, several studies have
forced us to reexamine this assumption. For example, blunting
the course of antigen presentation by antibiotic treatment
following Listeria monocytogenes infection has been shown to
have little impact on the onset of T cell contraction (Badovinac
et al., 2002; Mercado et al., 2000). Moreover, it has been demon-
strated that limiting antigen presentation through DTR-mediated
ablation of dendritic cells does not interfere with the generation
of normal memory T cell function (Prlic et al., 2006). These
results have led to the suggestion that contraction is pro-
grammed early after initial antigen encounter, in line with the
‘‘autopilot’’ model of CD8+ T cell immunity (Badovinac et al.,
2004; Bevan and Fink, 2001; Kaech and Ahmed, 2001; van Stip-
donk et al., 2001).
However, a limitation of previously reported experimental
systems is that contraction was defined indirectly, as a decline
in absolute T cell numbers, without specifically examining
T cell apoptosis. In fact, although several methods are currently
available to detect apoptosis in vitro (Elmore, 2007), it has been
challenging to apply these approaches to an in vivo setting due in
large part to the rapid clearance of dying cells by phagocytes
(Bahl et al., 2010). This is illustrated by the finding that fewhors
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(C) Intracellular staining for activated caspase-3
in sorted FRETpos (black) and FRETneg (green)
T cells conditioned as in (B). Numbers adjacent
to defined areas indicate percent cells in each
gate. Data are representative of two experiments
run in duplicate (B) or of three mice from two
experiments (C).thymocytes undergoing apoptosis can be detected at any given
time point within the thymus, despite the fact that >95% of them
are destined to die (Surh and Sprent, 1994). Inferring contraction
from a decrease in absolute T cell numbers has additional draw-
backs. For instance, the exact moment in which contraction
begins is difficult to precisely define as T cell apoptosis and
proliferation may occur simultaneously. In addition, although it
has traditionally been thought that peripheral tissues, such as
the liver and lungs, may represent the dominant sites of T cell
death (Huang et al., 1994; McKinstry et al., 2010), the difficulty
in directly identifying cells undergoing apoptosis in vivo has pre-
vented a thorough assessment of where T cell contraction is
occurring.
Herein, we established an in vivo approach to directly assess
T cell contraction by visualizing cells undergoing apoptosis.
Because both the extrinsic and intrinsic pathways of apoptosis
converge to activate the same executioner caspase-3, we intro-
duced a genetically encoded FRET-based reporter for caspase-
3 activity into naive CD8+ T cells (Breart et al., 2008; Tyas et al.,
2000). We show that this probe identifies T cells as they enter the
early phases of apoptosis. Using a combination of flow cytome-
try and two-photon imaging, we characterize the location,
phenotype and dynamics of T cells undergoing contraction. In
addition, we identify a critical window of time during which late
antigen re-encounter antagonizes contraction, suggesting
a causal link between antigen clearance and T cell contraction.Cell Reports 2, 1438–1447, NoRESULTS
Detecting Caspase-3 Activation in
TCells Using aGenetically Encoded
FRET-Based Reporter
Tracking T cell contraction in vivo has
been hampered by the difficulty in de-
tecting cells undergoing apoptosis. In
particular, late markers of apoptosis
such as Annexin V and TUNEL provide
only partial quantitative information
in vivo as apoptotic cells are rapidly
scavenged by phagocytic cells (Bahlet al., 2010; Surh and Sprent, 1994). To circumvent this
problem, we developed a system that allowed us to discrimi-
nate cells with caspase-3 activity, an early marker of apoptosis.
A FRET-based probe (Breart et al., 2008; Tyas et al., 2000),
composed of CFP and YFP molecules linked by the DEVD cas-
pase-3 cleavage sequence (referred to as DEVD) was retrovir-
ally transduced into cycling bone marrow (BM) cells. As
a control, we also included a construct encoding the noncleav-
able DEVG linker (Figure 1A). Following reconstitution of lethally
irradiated recipient mice, we validated the specificity and sensi-
tivity of reporter activity (Figure 1). Specifically, we character-
ized the caspase-3 reporter activity in T cells using conven-
tional inducers of apoptosis. T cells isolated from DEVD
chimeras were activated in vitro and then treated with anti-
CD3 + IL-2 to induce activation-induced cell death (AICD) or
with staurosporine to pharmacologically induce apoptosis.
After 7 days of culture, approximately 12% of DEVD T cells ex-
hibited FRET loss (referred to as FRETneg). This was elevated to
32% and 48% following treatment with anti-CD3 + IL-2 and
staurosporine, respectively (Figure 1B). Importantly, Annexin V
staining was restricted to DEVD T cells exhibiting FRET loss.
Although control DEVG T cells were sensitive to the apoptotic
stimuli, as detected by Annexin V reactivity, <2% were FRETneg.
Of note, FRETneg but not FRETpos T cells were stained
with an antibody directed against activated caspase-3 (Fig-
ure 1C). These results establish the reliability of our systemvember 29, 2012 ª2012 The Authors 1439
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Figure 2. Caspase-3 Activity in T Cells Is
Associated with Loss of Motility and Cell
Death In Vivo
Recipients were adoptively transferred with OT-I
DEVD T cells and immunized with peptide plus
LPS. Intact lymph nodes were subjected to two-
photon imaging at days 5–8.
(A) Set-up.
(B and C) Time-lapse image (B) and tracked
trajectories (C) of viable FRETpos (orange) and
apoptotic FRETneg (green) DEVD T cells.
(D) DISC analyses of imaging data set correlating
FRET negativity, cell arrest, and cell size.
(E and F) Time-lapse images illustrate two exam-
ples of viable DEVD T cell (0 min; orange) tran-
sitioning through apoptosis (green). Morphologic
changes in cellular integrity are evident at time
31 min (E) and 23 min (F). Data are representative
of eight movies obtained in two independent
experiments.
See also Figures S1 and S2.to detect, in a noninvasive manner, caspase-3 activity in
primary T cells.
Caspase-3 Activity in T Cells at the Peak of the
Response Is Associated with Loss of Motility and Cell
Death
We next investigated the occurrence and fate of caspase-3
reporter positive T cells in vivo. To this end, we studied the
response of adoptively transferred naive OT-I T cells expressing
the DEVD probe following immunization with adjuvant and
cognate peptide OVA257–264 (OVAp) (Figure 2A). Consistent
with the literature (Harty and Badovinac, 2008), we found the
peak of expansion to be between days 5 and 8 (Figure S1). We
used two-photon imaging of lymph nodes to relate changes in
T cell behavior and morphology to FRET loss (Figure 2). As
shown in Figure 2B, FRETpos and FRETneg T cells were clearly
discernable. At the peak of the response, we found that FRETpos
T cells were highly motile in the lymph node, displaying typical
velocities (10–15 mm/min) characteristic of viable T cells (Fig-
ure 2C; Movie S1). Interestingly, both arrested FRETneg T cells
and debris were evident throughout the imaging field (Movie
S1), with only a minor fraction (<10%) of FRETneg T cells remain-
ing motile throughout the duration of the movie. To further corre-
late T cell velocity and FRET levels, we took advantage of
dynamic in situ cytometry (DISC), a methodology we have
recently developed in which imaging data sets are processed,
converted into flow cytometry-like files and subjected to multi-
parametric analysis using flow cytometry software (Moreau1440 Cell Reports 2, 1438–1447, November 29, 2012 ª2012 The Authorset al., 2012). As shown in Figure 2D, the
majority of T cells exhibiting FRET loss
displayed mean velocities <2 mm/min.
Further gating of DISC data on FRETneg
and FRETpos cells revealed that FRETneg
cells displayed a smaller cell size
compared to FRETpos cells (Figure 2D).
We next focused our attention on T cellsthat transitioned from a reporter FRETpos to FRETneg state. Of
all events analyzed (11/11), T cells arrested before or during
the transition to FRETneg (Figure S2). Importantly, following
arrest, cells exhibited morphological changes consistent with
cell death (Figures 2E and 2F; Movie S2). Further movement of
FRETneg debris was presumably the result of phagocytosis, sug-
gesting rapid clearance after cell death. Taken together, these
data provide strong evidence that caspase-3 reporter activity
primarily marks T cells undergoing apoptosis. In addition, we
demonstrate that induction of caspase-3 activity in T cells is
associated with loss of motility followed within minutes by cell
death.
T Cell Contraction Is a Systemic Process Initiated Prior
to the Peak of Expansion
Although T cell contraction typically refers to the phase that
immediately follows the peak of expansion, the precise timing
as well as the exact location of contraction remains ill-defined.
We therefore investigated the kinetics of caspase-3 reporter
activity in the spleen of recipient mice transferred with DEVD
OT-I T cells following immunization with LPS plus peptide using
flow cytometry (Figure 3A). Caspase-3 activity, as detected by
FRET loss, was negligible (<1% of T cells) prior to immunization,
but reached 5%–6% by days 5–8 before declining to baseline
levels by day 23 (Figures 3B and 3C). Importantly, OT-I T cells ex-
pressing the control DEVG probe did not exhibit FRET loss, con-
firming the specificity of measurements made with the DEVD
probe (Figure 3C). Moreover, in contrast to FRETpos T cells,
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Figure 3. Identification of T Cells Under-
going Apoptosis during the Course of an
Immune Response
Recipient mice adoptively transferred with OT-I
DEVD T cells (or control OT-I DEVG T cells) were
immunized with peptide plus LPS. At the indicated
time, the spleen was harvested and analyzed by
FACS.
(A) Set-up.
(B) Frequency of FRETneg T cells prior to injection
(pre-inject) or in the spleen at the indicated time
postimmunization. Data are gated on OT-I T cells.
(C) FRETlossmeasured in the spleen at day 5 during
the response of OT-I DEVD or OT-I DEVG T cells.
(D) FRETneg (green line) and FRETpos (black line)
OT-I T cells from the spleen were sorted 5 days
after immunization and DNA fragmentation was
assessed using a TUNEL assay. Representative of
three animals from two experiments.
(E) Phenotype of gated splenic FRETneg (green line)
and FRETpos (black lines) OT-I T cells on day 12
following staining with KLRG1 and CD127 (IL-7Ra)
mAb.Data are representativeof three animals from
two experiments.
See also Figure S3.most OT-I T cells displaying FRET loss were undergoing
apoptosis, as detected by TUNEL staining (4% versus 82%
TUNEL+ T cells, respectively) (Figure 3D). These results establish
that T cells undergoing apoptosis can be directly identified using
a genetically encoded reporter for caspase-3 and reveal that the
rate of contraction is maximal at the peak of the response, i.e.,
before a substantial decrease in total OT-I T cell numbers could
be appreciated.
It has been proposed that effector CD8+ T cells can be subdi-
vided into KLRG1+IL-7Ra short-lived effector cells and
KLRG1IL-7Ra+ memory precursor cells (Joshi et al., 2007).
Our reporter allowed us to readily examine the phenotype of
T cells undergoing apoptosis. Although KLRG1+ cells were over-
represented in the fraction of apoptotic T cells at day 12,
contraction targeted both KLRG1+ and KLRG1 T cell subsets
and themajority of these cells also expressed IL-7Ra (Figure 3E).
At an earlier time point (d5), we note that both IL-7Ra and IL-
7Ra+ T cells undergo contraction although apoptosis was
more frequent in the IL-7Ra subset (Figure S3). Our results
therefore indicate that T cell contraction, in our set-up, is not
uniquely restricted to the KLRG1+IL-7Ra population, but rather
targets phenotypically diverse populations of activated T cells.
We next extended our analysis to different tissues. We were
consistently able to detect reporter positive cells in all locations
analyzed, including spleen, lymph node, PBL, BM, liver, lungs,
and thymus (Figure 4A). The rate of apoptosis was remarkably
similar in all tissues analyzed, thus revealing contraction is
a systemic process. As a consequence, when absolute numbers
were calculated, the spleen (containing the largest pool of OT-I
effector T cells [Figure S1]) was found to be the major site for
contraction (Figure 4B). Similar results were obtained in the
context of a bacterial infection using OVA-expressing Listeria
monocytogenes (LM-OVA) (Figure S4). To examine T cell
contraction in the context of a local immunization, we followed
the rate of T cell apoptosis upon subcutaneous injection of adju-Cell Revant plus cognate peptide (Figure 4C). The rate of contraction
was identical in the draining and nondraining lymph nodes as
well as in the spleen (Figure 4D). Altogether, our results indicate
that T cell contraction occurs systemically, irrespective of the
site of priming. The fact that the rate of apoptosis is similar in
all organs tested despite extensive variations in macrophages
frequencies (Figure S5), suggest that the phagocytic activity is
not limiting in vivo.
Monitoring T Cell Susceptibility to Apoptosis over the
Course of an Immune Response
Our results demonstrate that the frequency of apoptotic T cells
measured in vivo varied over the course of the response, peaking
at days 5–8. We reasoned that by removing contracting T cells
from their intact environment (and possibly preventing their rapid
phagocytosis),we shouldbeable tomeasure,with ahigher sensi-
tivity, their underlying propensity to die. To this end, we cultured
T cells at various stages of the responseandmeasured the induc-
tion of apoptosis following a short (2–3 hr) incubation period (Fig-
ure 5A). As shown in Figure 5B, activated OT-I T cells isolated at
day 8 progressively accumulated within the FRETneg population
over the 3 hr incubation. This induction of T cell apoptosis was
consistently detected in all ex vivo organ cultures analyzed (Fig-
ure 5C). Mirroring our in vivo observations, T cell susceptibly to
apoptosis in vitro varied over the course of the response, with
maximal death occurring at day 5 and substantially decreasing
by day 15 (Figure 5C). Collectively, our results demonstrate that
the observed changes in the frequencyof apoptotic T cells during
the responseaccurately reflectsdifferences inTcell susceptibility
to apoptosis over the course of the response.
Sustained Antigen Recognition Antagonizes T Cell
Contraction
Antigen clearance and T cell contraction often coincide; there-
fore it has been proposed that these events are linked. Moreports 2, 1438–1447, November 29, 2012 ª2012 The Authors 1441
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Figure 4. T Cell Contraction Is a Systemic
Process
(A and B) Recipient mice adoptively transferred
with OT-I DEVD T cells were immunized i.v with
peptide plus LPS. (A) Frequency of FRETneg T cells
in the indicated tissue 5 days postimmunization.
Numbers represent percent cells in the indicated
gate. (B) Total FRETneg T cells in distinct tissues at
the indicated time points. Data are representative
of five experiments.
(C) Set-up. Recipient mice adoptively transferred
with OT-I DEVD T cells were immunized subcuta-
neously with peptide plus LPS.
(D) Frequency of FRETneg T cells 5 or 8 days
following subcutaneous immunization was as-
sessed in the draining LN (dLN), nondraining LN
(non-dLN), and spleen. Representative of three to
four animals from two experiments. Data are pre-
sented as mean ± SEM.
See also Figures S4 and S5.recent work has challenged this belief and suggested that the
kinetics of T cell contraction is independent of antigen persis-
tence (Harty and Badovinac, 2008). To resolve whether the deci-
sion to undergo apoptosis is imprinted upon priming or whether
late antigen recognition events could influence T cell sensitivity
to apoptosis, we first assessed antigen availability over the
course of the response. By transferring a cohort of CFSE-labeled
OT-I T cells at various time points following immunization, we
noted that antigen availability sharply decreased by days 5–8,
coinciding with the bulk of contraction (Figure S6). To assess
whether decreasing levels of antigen were the underlying mech-
anism for enhanced susceptibility to apoptosis as measured in
our in vitro assay, we incubated T cells isolated at various time
points postimmunization with cognate peptide (Figure 6A). Strik-
ingly, TCR stimulation provided by OVAp during these brief 3 hr
cultures profoundly limited T cell sensitivity to apoptosis. This
effect was apparent up to 12 days postimmunization (Figure 6B).
To test whether TCR stimulation could also antagonize T cell
contraction in vivo, we provided a cohort of immunized animals
with an antigen bolus at day 4 and assessed T cell apoptosis the
following day (Figures 6C–6F). Increasing antigen availability
in vivo sharply reduced T cell susceptibility to apoptosis (Figures
6D and 6F). Moreover, this protection from apoptosis was re-
flected in enhanced levels of the prosurvival factor Bcl-xL (Fig-
ure 6E). Interestingly, augmenting antigen availability at later
time points in the response (day 7) had the opposite effect (Fig-
ure 6G), presumably reflecting the well-characterized activation-
induced cell death (Krammer et al., 2007). The differential modu-
lation of caspase-3 activity by antigen at day 4 compared to day
7 was reflected in alterations in the frequency of T cells recov-1442 Cell Reports 2, 1438–1447, November 29, 2012 ª2012 The Authorsered (Figure 6H). Thus, our data identify
a window of time during which T cell re-
encounter with antigen antagonizes
contraction. In particular, the finding that
T cell susceptibility to apoptosis could
be manipulated implies that T cells can
actively sense changeswithin their micro-environment and therefore, that T cell contraction is not fully pro-
grammed upon initial antigen recognition.
Although our data demonstrate a role for antigen in antago-
nizing contraction, it remained to be determined whether late
TCR engagement was acting in a cell autonomous manner to
promote survival or whether the effects were mediated through
the production of prosurvival factors, or both. To address these
questions, mice were transferred with OT-I DEVD reporter T cells
plus CD8+ T cells expressing the pmel-1 TCR (specific for
gp10025–33 peptide) admixture and immunized with both
cognate peptides (Figure 6I). We reasoned that if late TCR recog-
nition was reducing T cell contraction through the production of
prosurvival factors, then prolonging the availability of gp10025–33
to pmel-1 T cells should also antagonize the contraction of
bystander OT-I T cells. Supporting this hypothesis, we found
that injection of a bolus of gp10025–33 peptide at day 4 substan-
tially decreasedOT-I T cell susceptibility to apoptosis (Figure 6J).
Of note, the protective effect provided by injection of OVAp was
evenmoreprofound than that providedbygp10025–33 (Figure 6J),
possibly revealing a cell-intrinsic consequence of TCR re-
engagement. In sum, our results support the idea that T cell
contraction is governed by antigen availability and that late
TCR engagement can antagonize T cell apoptosis, at least in
part, through prosurvival factors acting in trans.
DISCUSSION
In the present article, we have characterized the anatomy of
T cell contraction during the course of CD8+ T cell responses.
We report that contraction is a systemic process, occurring at
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Figure 5. T Cell Susceptibility to Apoptosis
Monitored over the Course of an Immune
Response
(A) Schematic depicts OT-I DEVD T cell transfer
and peptide immunization of recipient mice. On
the specified day, the indicated tissue was har-
vested and after a brief in vitro incubation analyzed
by FACS.
(B) Frequency of FRET loss after a 2–3 hr incuba-
tion in OT-I DEVD T cells 8 days after immuniza-
tion. Three-hour incubation with staurosporine
was included as a positive control for apoptosis.
Numbers within defined areas indicate percent
cells in each gate.
(C) Frequency of FRETneg T cells following a 3 hr
incubation. Data are representative of five experi-
ments.the same rate in lymphoid and nonlymphoid compartments.
Moreover, we provide evidence that T cell contraction is regu-
lated by antigen availability. Specifically, we identify a critical
window of time during which T cell fate remains flexible and
sensitive to changes in the microenvironment. Taken together,
our results suggest that in contrast to the notion that contraction
is a hard-wired program, the decision to undergo apoptosis is
a stochastic process largely influenced by cell-extrinsic factors,
with late antigen-dependent signals acting as apical mediators
of effector T cell survival.
We have introduced a methodology for identifying in real-time
the onset of apoptosis using a genetically encoded reporter for
caspase-3 activity. Our technique offers additional advantages
over conventional approaches for detection of apoptosis. First,
our approach allows the direct identification of apoptotic cells
without further in vitro manipulation. Second, viable T cells tran-
sitioning to the early phase of apoptosis can be isolated for
further ex vivo interrogation. Finally, when combined with
imaging, our approach permits the visualization of contraction
as it occurs over the course of an immune response.
Noteworthy, although caspase-3 activation is a classic hall-
mark of both the intrinsic and extrinsic pathways of apoptosis,
recent work has indicated that caspase-3 activation can also
be associated with nonapoptotic processes (Alam et al., 1999;
McComb et al., 2010; Puga et al., 2008) and may even be
dispensable for contraction (Murakami et al., 2010; Nussbaum
and Whitton, 2004). In our system, however, caspase-3 reporter
activity corresponded to apoptosis as measured by TUNEL.
Furthermore, our two-photon imaging data provided additional
evidence that induction of caspase-3 reporter activity resulted
in behavioral and morphological changes associated with
apoptotic cell death in the vastmajority of T cells analyzed. DyingCell Reports 2, 1438–1447, NoT cells were cleared within minutes,
presumably explaining why the frequency
of FRETneg cells never exceeded 10%,
even at the peak of contraction. Collec-
tively, our methodology is broadly suited
to study apoptosis in vivo in many cell
types under a variety of immunologicalprocesses including thymocyte development, dendritic cell acti-
vation and immune cell homeostasis.
The course of a T cell response is traditionally divided into
discrete phases of proliferation, contraction, and subsequent
memory formation. Such a three-phase model would predict
that the rate of contraction would progressively increase after
the peak of the response. In contrast, our results revealed that
the maximal rate of T cell apoptosis occurred concurrently
with the peakof expansion. This observation implies a substantial
degree of overlap between proliferation and death. Furthermore,
the location of T cell contraction has been controversial and may
well vary based on the experimental model. For example, LCMV-
specific CD8+ T cells from lymphoid organs have been shown to
be more susceptible to apoptosis than their peripheral counter-
parts (Wang et al., 2003). Conversely, influenza-specific T cells
preferentially die in infected tissue rather than lymphoid organs
(McKinstry et al., 2010). We performed a thorough quantification
of T cell apoptosis during local and systemic immunization. We
found the frequency of dying T cells to be similar in all organs
and tissues analyzed indicating that contraction is by large
a systemic process. Furthermore, it has been suggested that
T cells harboring a KLRG1+ IL7Ra phenotype were fated to
die in contrast to KLRG1IL-7Ra+ memory precursor cells.
Although the proportion of KLRG1+ T cells was indeed increased
in T cells undergoing apoptosis, KLRG1 T cells still represented
approximately half of the subset of dyingTcells andmost of these
cells expressed IL-7Ra. Thus, in our settings, T cell contraction
targets phenotypically diverse T cell subsets.
A critical question is whether the timing of T cell apoptosis is
dictated early on during the priming phase or at later stages as
T cells perceive changes in their environment. In particular, the
role of antigen clearance in initiating contraction has remainedvember 29, 2012 ª2012 The Authors 1443
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Figure 6. Late Antigen Encounters Antago-
nize T Cell Contraction
(A and B) OT-I DEVD T cells were adoptively
transferred into recipient mice and immunized with
peptide plus LPS the following day. At the indi-
cated time, splenocytes were cultured for 3 hr in
the presence (3 hr + OVAp) or absence of OVA
peptide (3 hr).
(C–H) Recipients received OT-I DEVD T cells the
day prior to immunization. Four (D–F, H) or 7 days
(G, H) later, animals received an additional peptide
bolus (or PBS) and the following day splenocytes
were analyzed by FACS. (D, F) Frequency of
FRETneg T cells following a 3 hr incubation in media
alone (3 hr) or in the presence of OVApeptide (3 hr +
OVAp) in animals that had received a bolus of
antigen or PBS at day 4 (n = 3–4; each group).
Numberswithindefinedareas indicatepercentcells
in each gate (D). Data shown are derived from three
animals representing one of three experiments. (E)
Expression of Bcl-xL at 5 and 6 days post-
immunization. Animals received either a peptide
bolus (white) or PBS (gray shaded) at day 4 (n = 2–3;
each group). Black filled histogram depicts isotype
control staining. (G) Frequency of FRETneg T cells
following a 3 hr incubation inmedia alone (3 hr) or in
the presence of OVA peptide (3 hr + OVAp) in
animals that had received or not a bolus of antigen
at day 7 (n = 3–4; each group). Samples were
analyzed 8 days postimmunization. (H) Frequency
of OT-I+ T cells recovered from spleen 8 days
postimmunization (Nil) or after day 4 or day 7
antigen bolus.
(I and J) Animals received a 1:1 OT-I DEVD:pmel-1
CD8+ T cell admixture. The following day animals
were immunized with LPS plus each respective
peptide and, at day 4, received an additional
antigen bolus. Splenocytes were analyzed at day 5
byFACS.Set-up (I) and frequencyofFRETnegTcells
following a3hr in vitro incubation (n=3; eachgroup)
(J). *p < 0.05, **p < 0.005, and ***p < 0.0005 (two-
tailed unpaired t test). Data are representative of
four (B) or two (E, F, J) experiments. Data are pre-
sented as mean ± SEM.
See also Figure S6.controversial (Badovinac and Harty, 2002; D’Cruz et al., 2009;
Marrack et al., 2010; McKinstry et al., 2010). With the ability to
dissect, at the single cell level, the effect of antigen re-encounter
on T cell survival, we provide evidence that sustained antigen
availability antagonizes contraction. This was unexpected given
that TCR re-engagement has been shown to induce AICD. In
fact, we found that antigen re-encounter has divergent effects
on T cell survival and could induce AICD as the response weans.
Specifically, we identified a window of time around the peak of
the response during which additional TCR signals dramatically
reduce caspase-3 activity, induce the anti-apoptotic mediator
Bcl-xL and increase the overall size of the surviving T cell pool.
We propose that this temporal window provides a mechanism
to maintain effector T cell viability until infection has been
cleared. The finding that T cells can be rescued from apoptosis
by antigen re-encounter supports a model in which a T cell’s
decision to undergo apoptosis is not fully imprinted during1444 Cell Reports 2, 1438–1447, November 29, 2012 ª2012 The Autpriming, but rather, the result of continuous signals received
from themicroenvironment. In contrast to CD4+ T cells, activated
CD8+ T cells have been shown to proliferate and differentiate in
the absence of continued antigenic stimulation (van Stipdonk
et al., 2001). However, recent work has shown that prolonged
antigen availability may be required for optimal CD8+ T cell
responses (Blair et al., 2011; Hovav et al., 2007; Jusforgues-Sa-
klani et al., 2008). By suggesting a causal link between antigen
availability and T cell contraction, our work further challenges
the idea that the fate of CD8+ T cells is completely hard-wired
following initial priming.
Our results would also be consistent with the observation that
stimulation by high-affinity peptide may limit T cell apoptosis
(Malherbe et al., 2004; Wensveen et al., 2010). While an optimal
priming could explain this observation, it is interesting to
consider that when antigen load becomes limiting in the late
phase of the response, T cells may only remain responsive tohors
high but not low-affinity ligands. High affinity TCR ligands may
act to limit the extent of contraction through sustained TCR stim-
ulation. This would be consistent with the observation that acti-
vation by low-affinity peptide induces an earlier onset of contrac-
tion than their high-affinity counterparts (Zehn et al., 2009) and
together with our work, suggests that contraction may be
a default pathway triggered in antigen poor conditions.
It has been well established that T cell contraction is greatly
influenced by cytokine signals (Badovinac et al., 2000; Joshi
et al., 2007; Rubinstein et al., 2008; Sanjabi et al., 2009; Schluns
and Lefranc¸ois, 2003). Our workmay help provide a link between
cytokine- and antigen-dependent processes during the contrac-
tion phase. Indeed, we found that the protective effect of antigen
re-encounter was extended to bystander effector T cells. Our
results thus imply a role for antigen-dependent soluble factors
that, acting in both an autocrine as well as paracrine manner,
promote T cell survival. In support, we have found the addition
of IL-2, IL-7, or IL-15 to our in vitro cultures antagonizes T cell
contraction, albeit to a lesser degree than cognate peptide
(K.R.G and P.B., unpublished data). Although the present work
has specifically focused on understanding factors underlying
the contraction phase of T cell responses, our approach could
readily be applied in future studies to help dissect the mecha-
nisms driving memory T cell differentiation.
In sum, by employing a genetically based strategy to track
effector T cell apoptosis, we have provided insights into an enig-
matic phase of adaptive immunity. Specifically, we have demon-
strated that contraction occurs concurrently with the expansion
phase and is detected at similar rates in both the lymphoid and
nonlymphoid compartments. In contrast to the belief that
contraction is a hard-wired program, our results highlight an
inherent plasticity in effector T cell fate during contraction and
suggest a prominent role for antigen availability in antagonizing
T cell apoptosis. Exploiting this plasticity and the prosurvival
effects of late antigen encounter may provide promising targets
for boosting immune responses.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and pmel-1 (gp10025–33 peptide-specific CD8
+ TCR-transgenic)
mice were purchased from Charles River and The Jackson Laboratory,
respectively. OT-I (OVA257–264 peptide-specific CD8
+ TCR-transgenic) mice
were bred in our animal facility. Mice were cared for in accordance with Pas-
teur Institute guidelines in compliance with European animal welfare regula-
tions, and all animal studies were approved by the Pasteur Institute Safety
Committee in accordance with French and European guidelines.
Bone Marrow Chimeras
DEVD and DEVG constructs (provided by J.M. Tavare´ [Tyas et al., 2000]) were
cloned into a murine stem cell virus (MSCV) vector using standard techniques.
Transduction of cycling C57BL/6 and OT-I BM cells was done as described
(Dahl et al., 2000; Pear et al., 1998) with the exception that Platinum-E pack-
aging cell line was used for production of retrovirus. Transgene+ cells were
selected on a FACSAria II (Becton Dickenson) and adoptively transferred
into lethally irradiated (two doses of 625 rads given at a 3 hr interval) recipients.
Mice were rested >8 weeks following BM reconstitution.
In Vitro Detection of Apoptotic Cells
CD4+ T cells from C57BL/6 BM chimeras were purified from lymphoid organs
using Dynabead negative selection and activated with a-CD3/CD28 beadsCell Re(25 ml/106 T cells; Invitrogen) under Th1 skewing (10 ng/ml IL-12 and 10 U/ml
IL-2; Invitrogen and Roche, respectively) conditions. After 6 days, cells were
left untreated or treated overnight with either staurosporine (1 mM; Sigma-
Aldrich) or soluble a-CD3 (1 mg/ml; eBioscience) plus IL-2 (50 U/ml) to induce
AICD. The following day, samples were stained for Annexin V as per manufac-
turer’s instructions (eBioscience) and analyzed by a BD FACSCanto II. In
similar experiments, day 7 samples were sorted into FRETpos and FRETneg
populations and stained for intracellular activated caspase-3 (C92-605; BD
PharMingen) expression as permanufacturer’s instructions (Cytofix/Cytoperm
kit; BD Bioscience).Monitoring Contraction In Vivo
CD8+ T cells fromOT-I BM chimeras were purified from lymphoid organs using
Dynabead negative selection and 0.5-1 3 106 OT-I DEVD T cells were trans-
ferred to recipient mice. The following day, animals were immunized intrave-
nously (i.v.) with OVA257–264 plus OVA323–339 (100 mg each peptide; PolyPep-
tide Group) in LPS (40 mg Escherichia coli 026:B6; Sigma-Aldrich) in a single
dose i.v. or in two equal doses subcutaneously. The immunodominant
OVA323-339 was included to promote endogenous CD4
+ T cell help (Williams
and Bevan, 2007). Other recipients were infected i.v. with 2 3 104 CFU
OVA-expressing Listeria monocytogenes (LM-OVA). For some peptide-immu-
nized animals, a bolus of either 100 mg OVA257-264 or an equal volume of PBS
was administered at the indicated time. In additional experiments, animals
received a 1:1 mixture of 1 3 106 pmel-1:OT-I DEVD CD8+ T cells and were
immunized the following day with OVA257–264, OVA323–339, and gp10025–33
(100 mg each peptide; AnaSpec) in LPS. Four days later, animals received
a 100 mg bolus of either OVA257–264, gp10025–33, or an equal volume of PBS.
At the indicated time, single cell suspensions were prepared from nonlym-
phoid and/or lymphoid organs and RBC-lysis (eBioscience) was performed.
Lymphocytes from the liver were enriched using a density gradient (Histopa-
que-1077; Sigma-Aldrich). All samples were extensively washed, resus-
pended in complete T cell media46and either directly analyzed by FACS or
cultured 2–3 hr at 37C. Some 3 hr cultures received 1 mg/ml OVA257–264.Quantification of Apoptosis
FACS samples were gated with the following strategy to quantify apoptotic
events: doublet exclusion, FSC/SSC viable lymphocytes, SSC/YFP transgene
expression, and FRET gate. Greater than 99% of the adoptively transferred
OT-I DEVD reporter T cells were double positive for CD8 and Vb5. Samples
were analyzed on a BD FACSCanto II (peptide immunized mice) or a LSR II
(LM-OVA infected mice). The parameter FRETloss was defined using the
FlowJo software as the ratio of CFP to FRET fluorescence. DNA fragmentation
was assessed on FRETneg and FRETpos OT-I DEVD T cells that were FACS
sorted from the spleen 5 days after immunization using an Apo-BrdU
Apoptosis Detection kit (eBioscience) with a BrdU monoclonal antibody
(MoBU-1; Invitrogen).Two-Photon Imaging and Analysis
Five to eight days after peptide immunization of mice transferred with OT-I
DEVD T cells, LN were harvested and two-photon imaging was performed
using an upright microscope (DM6000B, Leica Microsystems) with a
203/0.95 NA water-dipping objective (Olympus). Excitation was provided by
a Chameleon Ultra Ti:Sapphire (Coherent) tuned at 880 nm. Data sets were
processed and analyzed using Imaris (Bitplane) and the custom designed
DISCit software for conversion into FCS files (Moreau et al., 2012).Statistical Analysis
Statistical significance was calculated using a Student’s t test. p values < 0.05
were considered significant. Data are presented as mean ± SEM.SUPPLEMENTAL INFORMATION
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